Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of superior mesenteric artery (SMA) adherent tissue in the context of pancreatic head resections- an observational study.

BMC cancer·2026
Same author

Reducing healthcare access inequities in West Java through forecasting and location-allocation models.

BMC health services research·2026
Same author

Prevention first - modelling evidence-based prevention with the dental team for children in England.

British dental journal·2026
Same author

Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

Health technology assessment (Winchester, England)·2026
Same author

An optimisation framework for resource allocation in palliative and end-of-life care.

Scientific reports·2026
Same author

High-Flow Nasal Cannula During Endobronchial Ultrasound: New Physiologic Insights From a Randomized Trial.

Respiratory care·2026
Same journal

Causal intervention validation of gene regulatory signals in scGPT.

Journal of biomedical informatics·2026
Same journal

CoAff-DTI: Fine-grained drug-target interaction prediction using pre-trained language models and affinity-guided mechanisms.

Journal of biomedical informatics·2026
Same journal

Evaluation of temporal preservation in synthetic longitudinal patient data.

Journal of biomedical informatics·2026
Same journal

ARKE: An ontology-driven framework for automated mapping of local radiology procedure terms to the LOINC-RadLex playbook using large language model.

Journal of biomedical informatics·2026
Same journal

A validation-driven training controller for cross-lingual biomedical NER via reinforcement learning-based adaptive loss weighting.

Journal of biomedical informatics·2026
Same journal

ASP-HR: An Adaptive Spatial Perception and Hierarchical Reasoning mechanism for document-level biomedical relation extraction.

Journal of biomedical informatics·2026
See all related articles

Related Experiment Video

Updated: Nov 24, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

709

Modified Needleman-Wunsch algorithm for clinical pathway clustering.

Emma Aspland1, Paul R Harper1, Daniel Gartner1

  • 1School of Mathematics, Cardiff University, Cardiff, United Kingdom.

Journal of Biomedical Informatics
|December 28, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a new algorithm to improve clinical pathway analysis by integrating expert knowledge into data mining. This enhances the accuracy of clustering patient pathways for better healthcare standardization.

Keywords:
Clinical pathwaysData miningLung cancer

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K

Related Experiment Videos

Last Updated: Nov 24, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

709
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K

Area of Science:

  • Health Informatics
  • Data Mining
  • Computational Biology

Background:

  • Clinical pathways standardize care delivery to reduce variation in processes and patient outcomes.
  • Patient pathways are often represented as strings for data mining and clustering.
  • Existing distance metrics for string data lack contextual understanding, leading to arbitrary clustering results.

Purpose of the Study:

  • To develop a data mining technique integrating expert information with patient pathway data.
  • To create a novel string distance metric for process data, incorporating contextual information.
  • To improve the meaningfulness of clustering results in clinical pathway analysis.

Main Methods:

  • Focus on k-medoids clustering for string data representing patient pathways.
  • Evaluation of eight common string distance metrics for their applicability and limitations.
  • Development of the modified Needleman-Wunsch algorithm, incorporating expert-defined activity groupings and rankings for contextual similarity.

Main Results:

  • Standard distance metrics provide arbitrary distances without context, yielding varied clustering outcomes.
  • The modified Needleman-Wunsch algorithm successfully integrates expert knowledge into string similarity calculations.
  • The new metric allows for more meaningful clustering by adding context to pathway strings.

Conclusions:

  • Integrating expert knowledge via a novel string distance metric significantly enhances clinical pathway clustering.
  • The developed algorithm, applied to a lung cancer pathway, offers a flexible approach applicable to any disease type.
  • The Sim.Pro.Flow tool provides a publicly available decision support system for this enhanced pathway analysis.